.png){kind=icon}
Return
MAPDP: A Cloud-Based Computational Platform for Immunopeptidomics Analyses
.png){kind=icon}
PRE
AI
DOI：10.1021/acs.jproteome.9b00859.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The immunopeptidome corresponds to the repertoire of peptides presented at the cell surface by the major histocompatibility complex (MHC) molecules. Cytotoxic T cells scan this repertoire to identify nonself antigens that can arise from tumors or infected cells. The identification of actionable antigenic targets is key to the development of therapeutic cancer vaccines, T-cell therapy, and other T-cell receptor-based biologics. The growing clinical interest for immunopeptidomics has accelerated the development of high throughput proteogenomic platforms that provide a system-level analysis of MHC-associated peptides. Improvement in sensitivity and throughput of mass spectrometers now allows the detection of a few thousands of peptides from less than 100 million cells. To manage the amount of data generated by these instruments, we have developed the MHC-associated peptide discovery platform (MAPDP), a novel open-source cloud-based computational platform for immunopeptidomic analyses. It provides convenient access from a web portal to immunopeptidomes stored in the database, filtering tools, various visualizations, annotations (e.g., IEDB, dbSNP, gnomAD), peptide-binding affinity prediction (mhcflurry, NetMHC), HLA genotyping, and the generation of personalized proteome databases. MAPDP functionalities are demonstrated here by the discovery of MHC peptides featuring new genetic variants identified in two previously published ovarian carcinoma data sets.
Keywords:
bioinformatics
cloud
immunopeptidomics
major histocompatibility complex
mass spectrometry
minor antigen
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.6
Papers:
9.4K
Citations:
2.3W
Organization
Cited Papers
ShareSaveProteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.png)
LEUKEMIA
OAAI
LEUKEMIAIF13.4
OAAIShareSave
ShareSaveShareSaveShareSaveShareSave
View more